Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 12;18(2):56-60.
doi: 10.1002/jgf2.5. eCollection 2017 Apr.

Management of neuropathic pain

Noriko Nishikawa  1 , Masahiro Nomoto  1
Affiliations
Review

Management of neuropathic pain

Noriko Nishikawa et al. J Gen Fam Med. .

Abstract

Neuropathic pain is intractable pain caused by damage to the nervous system. Recent approval and expansion of the indications of a series of drugs are expected to improve the treatment strategies for neuropathic pain. Here, we present an outline of pain transmission pathways and relevant pharmacological effects, along with points to consider in the use of neuropathic pain medications according to the guidelines of Japan Society of Pain Clinicians. The content of this article is almost similar to my other Japanese article that was published in the Journal of the Japanese Society of Internal Medicine. Although complete recovery from pain may be difficult, pharmacotherapy can relieve pain, thereby improving the patients' quality of life.

Keywords: duloxetine; neuropathic pain; pregabalin; tramadol; tricyclic antidepressants.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Somatosensory pathway
Figure 2
Figure 2
Inhibitory regulation of neurotransmission in the spinal cord dorsal horn
Figure 3
Figure 3
VAS scale and face scale
See this image and copyright information in PMC

References

    1. Nishikawa N. Treatment of neuropathic pain. J Jpn Soc Int Med. 2013;102:2001–8. - PubMed
    1. Loesera JD, Treedeb RD. The Kyoto protocol of IASP Basic Pain Terminology. Pain. 2008;137:473–7. - PubMed
    1. Bouhassira D, Lantéri‐Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380–7. - PubMed
    1. Miaskowski C, Nurmikko TJ, Portenoy RK, et al. Pharmacologic management of neuropathic pain: evidence‐based recommendations. Pain. 2007;132:237–51. - PubMed
    1. Attal N, Cruccu G, Haanpää M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13:1153–69. - PubMed

LinkOut - more resources